effectively 'cocoons' the trauma victim away from triggers which stimulate unpleasant emotional reactions from specific reminders of the trauma as well as non-specific or partial 'cues'. Hyperarousal also develops with prominent hypervigilance and startle reactions. Those who have been traumatized never want it to happen again.
Unlike Dr Field I think that it is very easy to envisage 'a subject in a state of high anxiety with irritability, hypervigilance and an exaggerated startle response simultaneously exhibiting psychic numbing, emotional anaesthesia and loss of general responsiveness'. Emotional blunting represents avoidance at an emotional rather than a behavioural level.
Dr Field concludes that 'PTSD is nothing more than a collection of the psychological reactions that may occur after exposure to an emotionally traumatic event'. That is precisely what it is and it is a remarkably cohesive constellation. Not only that; PTSD has proven to be a very useful way of explaining how trauma victims recover psychologically from life-threat because the symptoms should be viewed as initially having a strong survival emphasis, actually helping people to come to terms with a traumatic experience. The conventional view is that PTSD should not be seen as a psychopathology until the reaction has become 'stuck' and chronically disabling. Most people recover from this psychological injury with adequate support and by using their own resources; and most of those who do not will respond to treatment. The outcome can be very positive.
If Dr Field's views on PTSD were generally accepted, in the face of compelling evidence to the contrary, then many genuinely suffering victims (not only of combat or earthquakes, volcanic eruptions, fires and miners trapped underground) would not receive the help they deserve. Published research in Britain and other developed countries shows conclusively that victims of road traffic accidents and personal attack (rape, robbery, violence and mugging) commonly develop enduring PTSD as well as depression and anxiety states.
Should serious psychological injuries such as these not receive the perfectly legitimate attention of the Courts, as well as broken limbs? PTSD is a robust psychiatric classification based on high-quality research from all over the world of proven value for both clinical and medicolegal purposes. It fully justifies its place as a cornerstone in our understanding of how human beings respond to severe challenge. If it is what Dr Field terms an 'umbrella diagnosis' then it must be a particularly encrusted one since it was unfolded long before its 'importation from the United States'. Homer, Pepys and Dickens all described the core features of PTSD quite independently of DSM-III. If the American authors of DSM-III had simply been copycats they would have had to look no further than Lady Percy's description of her husband, Hotspur, after he had returned from the Wars of the Roses 410 years ago (Henry IV, Part I, Act II, Scene III, lines 42-69).
Gordon Turnbull
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Complementary medicine
The January 1999 JRSM contains both an editorial (p. 1) and an article (p. 13) on this subject. But what constitutes 'complementary medicine'? Professor Ernst, in his editorial, does not define it; Dr Chandola and colleagues define it as 'one that offers a holistic approach, in contrast to orthodox medicine that is supposed to view the body mechanistically', including acupuncture and 'manual healing methods' (which encompass manipulation).
Good orthodox medicine has always been holistic in that the doctor is supposed to treat the patient rather than just the disease. Furthermore, what is regarded as orthodox medicine is constantly changing as it incorporates new therapies, some of which may have been used initially by those outside the medical profession formerly known as 'quacks'. Acupuncture is now used by many registered medical practitioners both in general practice and in pain clinics. Likewise, manipulation is now frequently used by 'orthodox' practitioners including general practitioners, orthopaedic surgeons and rheumatologists. There is mounting 'evidence' of its efficacy; but one of the difficulties in designing suitable trials (particularly controlled ones) is defining the appropriate indications. As in all other fields of medicine, initial results will show successes and failures; it is the analysis of these that leads to identification of those patients most likely to benefit from a specific treatment.
In the case of back pain, many articles have compared manipulation with other treatments without defining the type of back pain-which is, after all, only a symptom. One would scarcely expect a comparison of treatments of headache, chest pain or abdominal pain to be ofvalue without more definition of the 'syndrome' of symptoms and signs-even if one could not reach a precise pathological diagnosis.
We in musculoskeletal medicine are working towards the same goals as those in other fields trying to prescribe the treatment most likely to benefit the individual patient.
Malcolm Morrison
President, British Institute of Musculoskeletal Medicine, 17 Green Lane, Northwood, Middlesex HA6 2PX, UK Professor Ernst (January 1999 JRSM, pp. 1-2) challenges complementary medicine to 'come up with the goods and demonstrate what treatments are effective, safe and costeffective for which condition'. Primafacie, this would seem to represent common sense for any controversial issue in medicine. However, there is a barrier in the path of meeting this challenge, apart from the fact that this field of evaluation is both under-resourced and difficult. That barrier is reviewer bias. Systematic review is a powerful tool but it is not the end of the story. How the evidence is graded for methodological quality, synthesized into encapsulating statements and used to draw conclusions and make recommendations, demands a high level of rigour and an irreproachable freedom from bias.
Ernst points to one back pain triall (an undoubtedly 'random' example) in which one treatment arm consisted of a form of manipulation attributed to chiropractic. This trial showed little difference between any of three interventions and Ernst suggests that it 'has contributed to increasing doubts about whether chiropractic is helpful for acute uncomplicated low back pain in a clinically relevant way'. Readers, however, may not be aware that, at the time of the Royal College of General Practitioners' Clinical Guidelines and Evidence Review of Acute Back Pain2, there were 36 such trials of manipulation (many involving chiropractic) and 53 reviews of this evidence. Taking into consideration relevance, methodological quality and outcomes, these national clinical practice guidelines reflect little doubt, let alone increasing doubt, about the effectiveness of manipulation, chiropractic or otherwise.
How are clinicians and patients to deal with such inconsistencies? I suggest that, from now on, they ignore selective reference to individual trials. In terms of evidencebased practice, reference to one trial, unless it is of very high methodological quality and shows a clear superiority of one treatment over another, will reflect only the professional bias of the writer. It does not cast doubt on, confirm, or indicate any significant change in a large body of evidence. K Humphreys rightly draws attention to difficulties encountered in telemedicine trials. We do agree that results obtained via telemedicine need to be compared with those obtained via traditional practice. As he says, most of the work to date has concerned teleradiology and little is known about the diagnostic accuracy of other telemedicine applications. We have assessed the Spirophone, which allows expiratory pulmonary function tests at home and transmission via telephone to a remote-receiving centre. The Spirophone records maximal forced expiratory manoeuvres with acceptable accuracy, reliability, and reproducibility1-3.
We found it comparable to a standard laboratory spirometer for home monitoring of SVC, FVC, FEV1, and PEF4. The validity of the manoeuvre can be assessed on screen in the remote receiving centre in real time, and when necessary expert advice can be transmitted. We think that such a system could improve the management of asthma, cystic fibrosis and other respiratory diseases.
G Izbicki
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